Dr. Nasfat Shehadeh, M.D.
Claim this profileNovant Health Presbyterian Medical Center
Studies Breast Cancer
Studies Carcinoma
5 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
HER2 negative
HER2 positive
ER negative
2Carcinoma
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Nasfat Shehadeh, M.D. is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Tetrodotoxin
for Chemotherapy-Induced Neuropathic Pain
To be eligible for the trial, subjects must have ongoing moderate to severe neuropathic pain related to a prior course of platinum and/or taxane chemotherapy and have no clinical evidence of actively progressive disease. The trial period will comprise a Screening Period (up to 35 Days), a two-week period for the determinations of Baseline pain followed by randomization and 4-day treatment, followed by a 12-week follow up period (12 weeks total after initial treatment), and an End-of-Trial/Follow-up visit, which will occur at Week 13. This is a study to research the effects of the study drug on neuropathic pain compared placebo.
Recruiting0 awards Phase 211 criteria
More about Nasfat Shehadeh, M.D.
Clinical Trial Related9 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Nasfat Shehadeh, M.D. has experience with
- Surgery
- Active Monitoring
- Regional Nodal XRT
- Chestwall XRT
- WBI
- Single Cycle Tetrodotoxin
Breakdown of trials Nasfat Shehadeh, M.D. has run
Breast Cancer
Intraductal Carcinoma
Peripheral Neuropathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nasfat Shehadeh, M.D. specialize in?
Nasfat Shehadeh, M.D. focuses on Breast Cancer and Carcinoma. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are HER2 positive.
Is Nasfat Shehadeh, M.D. currently recruiting for clinical trials?
Yes, Nasfat Shehadeh, M.D. is currently recruiting for 2 clinical trials in Charlotte North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Nasfat Shehadeh, M.D. has studied deeply?
Yes, Nasfat Shehadeh, M.D. has studied treatments such as Surgery, Active Monitoring, Regional Nodal XRT.
What is the best way to schedule an appointment with Nasfat Shehadeh, M.D.?
Apply for one of the trials that Nasfat Shehadeh, M.D. is conducting.
What is the office address of Nasfat Shehadeh, M.D.?
The office of Nasfat Shehadeh, M.D. is located at: Novant Health Presbyterian Medical Center, Charlotte, North Carolina 28204 United States. This is the address for their practice at the Novant Health Presbyterian Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.